e.g. Tata motors, Reliance MF, 500570

Q-Line Biotech Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:
More:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 203.68 183.09 278.38
Expenses
Material consumed 101.22 93.99 150.60
Manufacturing expenses - - -
Personnel expenses 23.98 22.91 24.10
Selling expenses - 0.03 0.03
Adminstrative expenses 35.13 29.70 37.01
Expenses capitalised - - -
Cost of sales 160.33 146.63 211.74
Operating profit 43.34 36.46 66.64
Other recurring income 2.83 2.38 1.37
Adjusted PBDIT 46.17 38.84 68.01
Financial expenses 7.10 4.48 3.00
Depreciation 4.22 1.81 1.30
Other write offs - - -
Adjusted PBT 34.85 32.55 63.71
Tax charges 8.99 8.38 16.20
Adjusted PAT 25.85 24.17 47.51
Non recurring items - - -
Other non cash adjustments - - -
Reported net profit 25.85 24.17 47.51
Earnigs before appropriation 141.36 116.75 93.25
Equity dividend - - -
Preference dividend - - -
Dividend tax - - -
Retained earnings 141.36 116.75 93.25
Close
Add Q-Line Biotech Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Q-Line Biotech Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback